Does Mounjaro Cause Kidney Stones?
No direct evidence links Mounjaro (tirzepatide) to causing kidney stones. Clinical trials and post-marketing data report kidney-related issues like acute kidney injury or worsening chronic kidney disease in some patients, often tied to severe nausea, vomiting, or dehydration from gastrointestinal side effects—not stone formation itself.[1][2] Kidney stones form from concentrated urine minerals like calcium oxalate, and Mounjaro's main risks involve fluid loss rather than altering urine chemistry to promote stones.
What Kidney Side Effects Are Reported with Mounjaro?
Acute kidney injury occurred in 0.4% of trial patients on the 15 mg dose, typically from dehydration due to nausea (up to 22%) or diarrhea (up to 17%).[1] No trials specifically tracked kidney stones. Real-world reports on platforms like Drugs.com mention rare patient anecdotes of stones, but these lack causation proof and could stem from underlying conditions like obesity or diabetes, which Mounjaro treats.[3]
How Does Dehydration from Mounjaro Affect Kidneys?
Mounjaro slows gastric emptying, causing nausea and vomiting that lead to fluid loss. This reduces kidney blood flow, risking injury but not directly stones unless chronic. FDA labeling advises monitoring kidney function in at-risk patients and staying hydrated.[2] Drink extra water—aim for 8-10 glasses daily—to counter this.
Who Is at Higher Risk for Kidney Problems on Mounjaro?
Patients with pre-existing kidney disease, the elderly, or those with severe GI intolerance face higher odds of acute injury (up to 1.1% in some studies).[1] Diabetes and obesity independently raise kidney stone risk (2-3x higher prevalence), so track symptoms like flank pain or blood in urine.[4]
Can Mounjaro Worsen Existing Kidney Stones?
No specific data, but dehydration could concentrate urine and aggravate stones. A 2023 case series noted reversible kidney injury in GLP-1 users (like semaglutide), but stones weren't highlighted.[5] Consult a doctor before starting if you have stone history; they may adjust dose or monitor via blood tests.
How Does This Compare to Other GLP-1 Drugs Like Ozempic?
Similar profile: Ozempic (semaglutide) has dehydration-linked kidney injury reports (0.3-0.7%), no strong stone link.[6] Both classes prompt hydration warnings. Wegovy trials showed no excess kidney stones versus placebo.[1]
[1]: Mounjaro Prescribing Information, Eli Lilly (2023). Link
[2]: FDA Label for Tirzepatide (May 2024). Link
[3]: Drugs.com User Reviews for Mounjaro. Link
[4]: NIH: Kidney Stones in Diabetes (2022). Link
[5]: J Am Soc Nephrol: GLP-1 Agonists and AKI (2023). Link
[6]: Ozempic Prescribing Information, Novo Nordisk (2024). Link